Sfoglia per Corso Network oncology and precision medicine
Mostrati risultati da 1 a 11 di 11
Comprehensive genomic profiling on tissue and liquid biopsy for actionable mutations in advanced solid tumors
2026
Comprehensive profile in head and neck cancer patients treated with immunotherapy
2024
Immune receptor CD137 as a biomarker in solid tumors and potential immunotherapeutic target in glioblastoma
2024
Investigating circulating immunosuppression as novel biomarker and potential therapeutic target to overcome immunotherapy resistance in (R/M) HNSCC patients
2026
MIRROR: a miRNA regulation-level network-based algorithm to study sexual dimorphism in cancer
2025
Network analysis to dissect glioblastoma immunosuppression complexity: identification of C-type lectins as potential therapeutic candidates and biomarkers
2025
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a network analysis
2024
Phase I study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric and young adult patients affected by relapsed/refractory central nervous system tumors: preliminary data
2025
Precision oncology in head and neck squamous cell carcinoma: from circulating biomarkers of immunotherapy response to advanced spatial profiling in clinically relevant samples
2026
Probing neutrophils heterogeneity in Glioblastoma: how the metabolism shapes the function of immunosuppressive CD71+Neutrophils
2023
Prognostic role of BRCA1/2 mutation type and location in advanced high-grade ovarian cancer
2026
Mostrati risultati da 1 a 11 di 11
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile